A review on novel breast cancer therapies: Photodynamic therapy and plant derived agent induced cell death mechanisms

Anti-Cancer Agents in Medicinal Chemistry

Volumn 16, Issue 7, 2016, Pages 793-801

  Adimuriyil George, Blassan Plackal ^a   Abrahamse, Heidi ^a  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

Author keywords

Apoptosis; Breast cancer; Cancer treatment; Cell cycle; Photodynamic therapy; Plant derived agents

Indexed keywords

AZADIRACHTA INDICA EXTRACT; BRUCEA JAVANICA EXTRACT; CAMPTOTHECIN; CARVACROL; CURCUMIN; DILLENIA SUFFRUTICOSA EXTRACT; EPIPODOPHYLLOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INULA LINEARIIFOLIA EXTRACT; LECTIN; MANGIFERA PAJANG EXTRACT; METHYLANTHRAQUINONE; NIMBOLIDE; PANDANUS AMARYLLIFOLIUS EXTRACT; PERECKIA BLEO EXTRACT; PHOTOSENSITIZING AGENT; PHYLLANTHUS AMARUS EXTRACT; PLANT MEDICINAL PRODUCT; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RUBUS ELLIPTICUS EXTRACT; SCLEROCARYA BIRREA EXTRACT; SENNA AURICULATA EXTRACT; SESQUITERPENOID; STRESS ACTIVATED PROTEIN KINASE; TERMINALIA CHEBULA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCA ALKALOID; ZIZIPHUS JUJUBE EXTRACT;

APOPTOSIS; AUTOPHAGY; BREAST CANCER; CANCER INCIDENCE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DEATH; CYTOSKELETON; CYTOTOXICITY; ELECTROMAGNETIC RADIATION; ENDOPLASMIC RETICULUM; GENE MUTATION; GOLGI COMPLEX; HEREDITY; HUMAN; LIFESTYLE; LYSOSOME; MITOCHONDRION; NECROSIS; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; BREAST NEOPLASMS; CHEMISTRY; DRUG EFFECTS; PHOTOCHEMOTHERAPY; PLANT;

BREAST NEOPLASMS; CELL DEATH; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLANTS;

EID: 84973655840     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520615666151026094028     Document Type: Review

References (140)

1. Gill, J.K.; Maskarinec, G.; Wilkens, L.R.; Pike, M.C.; Henderson, B.E.; Kolonel, L.N. Nonsteroidal anti-inflammatory drugs and breast cancer risk: The multiethnic cohort. Am. J. Epidemiol., 2007, 166, 1150-1158.
2. Hortobagyi, G.N.; De la Garza Salazar, J.; Pritchard, K.; Amadori, D.; Haidinger, R.; Hudis, C.A.; Khaled, H.; Liu, M. C.; Martin, M.; Namer, M. The global breast cancer burden: Variations in epidemiology and survival. Clin. Breast Cancer, 2005, 6, 391-401.
3. The Lancet. Breast cancer in developing countries. Lancet, 2009, 374, 1567-1652.
4. Curtis, C.; Shah, S.P.; Chin, S.F.; Turashvili, G.; Rueda, O.M.; Dunning, M.J. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature, 2012, 486, 346-352.
5. Carey, L.A. Through a glass darkly: Advances in understanding breast cancer biology, 2000-2010. Clin. Breast Cancer, 2010, 10, 188-195.
6. Love, S. Ch 20. Diagnosis and types of breast cancer. Dr. Susan Love’s Breast Book (4th ed.). Cambridge, MA: Perseus Publishing, 2005.
7. Daewood, S.; Cristofanilli, M. What progress have we made in managing inflammatory breast cancer? Oncology, 2007, 21, 673-685.
8. Perou, C.M.; Sorlie, T.; Eisen, M.B.; Van de Rijn, M.; Jeffrey, S. S.; Rees, C.A.; Pollack, J.R.; Ross, D.T. Molecular portraits of human breast tumors. Nature, 2000, 406, 747-752.
9. Elujoba, A.A.; Odeleye, O.M.; Ogunyemi, C.M. Traditional medicine development for medical and dental primary health care delivery system in Africa. Afr. J. Tradit. Complement. Altern. Med., 2005, 2, 46-61.
10. Gordon, M.C.; David, J. Plants as a source of anticancer agents. J. Ethnopharmacol., 2005, 100, 72-79.
11. Siripong, P.; Hahnvajanawong, C.; Yahuafai, J.; Piyaviriykul, S.; Kanokmedhakul, K. Induction of apoptosis by rhinacanthone isolated from Rhinacanthus nasutus roots in human cervical carcinoma cells. Biol. Pharm. Bull., 2009, 32, 1251-1260.
12. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod., 2007, 70, 461-477.
13. Agullo, G.; Gamet-Payrastre, L.; Manenti, S.; Viala, C.; Remesy, C. Relationship between flavonoid structure and inhibition of phosphatidylinositol-3-kinase and protein kinase C inhibition. Biochem. Pharmacol., 1997, 53, 1649-1657.
14. Gerritsen, M.E.; Carley, W.W.; Ranges, G.E.; Shen, C.P.; Phan, S. A. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am. J. Pathol., 1995, 147, 278-292.
15. Svanberg, K.; Bendsoe, K.N.; Axelsson, J.; Andersson-Engels, S.; Svanberg, S. Photodynamic therapy: Superficial and interstitial illumination. J. Biomed. Opt., 2010, 15, 41502-41510.
16. Foote, C.S. Definition of type I and type II photosensitized oxidation. Photochem. Photobiol., 1991, 54, 659.
17. Grady, D. A 60-year-old woman trying to discontinue hormone replacement therapy. JAMA, 2002, 287, 2130-2137.
18. Hilgers, T.W.; Stanford, J.B. Creighton model na pro education technology for avoiding pregnancy. Use effectiveness. J. Reprod. Med., 1998, 43, 495-502.
19. Hoskins, K.; Stopfer, J.; Calzone, K. Assessment and counseling for women with a family history of breast cancer. A Guide for Clinicians. JAMA, 1995, 273, 577-585.
20. Malone, K.E.; Daling, J.R.; Thompson, J.D.; O’Brien, C.A.; Francisco, L.V.; Ostrander, E.A. BRCA1 mutations and breast cancer in the general population: Analysis in women before age 35 years and in women before age 45 years with first-degree family history. JAMA, 1998, 279, 922-929.
21. Haber, D. Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations. N. Engl. J. Med. 2002, 46, 1660-1661.
22. Khuder, S.A.; Mutgi, A.B.; Nugent, S. Smoking and breast cancer: A meta-analysis. Rev. Environ. Health, 2001, 16, 253-261.
23. Eniu, A.; Carlson, R.W.; Aziz, Z.; Bins, J.; Hortobagyi, G.N.; Bese, N.S.; Love, R.R.; Vikram, B.; Kurkure, A.; Anderson, B.O. Breast cancer in limited resource countries: treatment and allocation of resources. Breast J., 2006, 12, 38-53.
24. Tsai, R.J.; Dennis, L.K.; Lynch, C.F.; Snetselaar, L.G.; Zamba, G. K.D.; Scott-Conner, C. The risk of developing arm lymphedema among breast cancer survivors: A meta-analysis of treatment factors. Ann. Surg. Oncol., 2009, 16, 1959-1972.
25. Clarke, M.; Collins, R.; Darby, S.; Davies, C.; Elphinstone, P.; Evans, E.; Godwin, J. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and A Review on Novel Breast Cancer Therapies 15 year survival: an overview of the randomised trials. Lancet, 2005, 366, 2087-2106.
26. Ravdin, P.M.; Siminoff, L.A.; Davis, G.J. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. Am. J. Clin. Oncol. 2001, 19, 980-991.
27. Siminoff, L.A.; Gordon, N.H.; Silverman, P.; Budd, T.; Ravdin, P. M. A decision aid to assist in adjuvant therapy choices for breast cancer. Psychooncology, 2006, 15, 1001-1013.
28. Chen, Z.; Gu, K.; Zheng, Y.; Zheng, W.; Lu, W.; Shu, X. O. The use of complementary and alternative medicine among Chinese women with breast cancer. J. Altern. Complement. Med., 2008, 14, 1049-1055.
29. Gutheil, W.G.; Reed, G.; Ray, A.; Dhar, A. Crocetin: An agent derived from saffron for prevention and therapy for cancer. Curr. Pharm. Biotechnol., 2012, 13, 173-179.
30. Fabris, C.; Valduga, G.; Miotto, G.; Borsetto, L.; Jori, G.; Garbisa, S.; Reddi, E. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res., 2001, 61, 7495-7500.
31. Henderson, B.W.; Dougherty, T.J. How does photodynamic therapy work? Photochem. Photobiol., 1992, 55, 145-157.
32. Dolmans, D.E.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer, 2003, 3, 380-387.
33. Castano, A.P.; Mroz, P.; Hamblin, M.R. Photodynamic therapy and antitumour immunity. Nat. Rev. Cancer, 2006, 6, 535-545.
34. Gollnick, S.O.; Brackett, C.M. Enhancement of antitumour immunity by photodynamic therapy. Immunol. Res., 2010, 46, 216-226.
35. Nowis, D.; Makowski, M.; Stoklosa, T.; Legat, M.; Issat, T.; Golab, J. Direct tumour damage mechanisms of photodynamic therapy. Acta Biochimica. Polonica., 2005, 52, 339-352.
36. Kalka, K.; Merk, H.; Mukhtar, H. Photodynamic therapy in dermatology. J. Am. Acad. Dermatol., 2000, 42, 389-413.
37. Rosenthal, M.A.; Kavar, B.; Hill, J.S.; Morgan, D.J.; Nation, R.L.; Stylli, S.S.; Basser, R.L. Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J. Clin. Oncol., 2001, 19, 519-524.
38. Pushpan, S.K.; Venkatraman, S.; Anand, V.G.; Sankar, J.; Parmeswaran, D.; Ganesan, S.; Chandrashekar, T.K. Porphyrins in photodynamic therapy-A search for ideal photosensitizers. Curr. Med. Chem. Anticancer Agents, 2002, 2, 187-207.
39. Collaud, S.; Juzeniene, A.; Moan, J.; Lange, N. On the selectivity of 5-aminolevulinic acid induced protoporphyrin IX formation. Curr. Med. Chem. Anticancer Agents, 2004, 4, 301-316.
40. Calzavara-Pinton, P.G.; Venturini, M.; Sala, R. Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology. J. Eur. Acad. Dermatol. Venereol., 2007, 21, 293-302.
41. Issa, M.C.A.; Manela-Azulay, M. Photodynamic therapy: A review of the literature and image documentation. An. Bras. Dermatol., 2010, 85, 501-511.
42. Tynga, I.M.; Houreld, N.N.; Abrahamse, H. Induced cell death pathway post photodynamic therapy using a Metallophthalocyanine photosensitizer in breast cancer cells. Photomed. Laser Surg., 2014, 32, 205-211.
43. Tynga, I.M.; Houreld, N.N.; Abrahamse, H. The primary subcellular localization of Zinc phthalocyanine and its cellular impact on viability, proliferation and structure of breast cancer cells (MCF-7). J. Photochem. Photobiol. B Biol., 2013, 120, 171-176.
44. Manoto, S.L.; Abrahamse, H. Effect of a newly synthesized Zn sulfophthalocyanine derivative on cell morphology, viability, proliferation, and cytotoxicity in a human lung cancer cell line (A549). Lasers Med. Sci., 2011, 26, 523-530.
45. Castano, A.P.; Mroz, P.; Wu, M.X.; Hamblin, M.R. Photodynamic therapy plus low-dose cyclophosphamide generates antitumour immunity in a mouse model. Proc. Natl. Acad. Sci. USA, 2008, 105, 5495-5500.
46. Garg, A.D.; Nowis, D.; Golab, J.; Agostinis, P. Photodynamic therapy: Illuminating the road from cell death towards antitumour immunity. Apoptosis, 2010, 15, 1050-1071.
47. Firczuk, M.; Winiarska, M.; Szokalska, A.; Jodlowska, M.; Swiech, M.; Bojarczuk, K.; Salwa, P.; Nowis, D. Approaches to improve photodynamic therapy of cancer. Front. Biosci., 2011, 16, 208-224.
48. Engbrecht, B.W.; Menon, C.; Kachur, A.V.; Hahn, S.M.; Fraker, D. L. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Cancer Res., 1999, 59, 4334-4342.
49. Oleinick, N.L.; Morris, R.L.; Belichenko, I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci., 2002, 1, 21.
50. Yang, J.; Liu, X.; Bhalla, K.; Kim, C.N.; lbrado, A.M.; Cai, J.; Peng, T.; Jones, D.P.; Wang, X. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science, 1997, 275, 1129-1132.
51. Piette, J.; Volanti, C.; Vantieghem, A.; Matroule, J.Y.; Habraken, Y.; Agostinis, P. Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem. Pharmacol., 2003, 66, 1651-1659.
52. Dellinger, M. Apoptosis or necrosis following Photofrin photosensitization: Influence of the incubation protocol. Photochem. Photobiol., 1996, 64, 182-187.
53. Morgan, J.; Oseroff, A.R. Mitochondria-based photodynamic anticancer therapy. Adv. Drug Deliv. Rev., 2001, 49, 71-86.
54. Granville, D.J.; McManus, B.M.; Hunt, D.W. Photodynamic therapy: Shedding light on the biochemical pathways regulating porphyrin-mediated cell death. Histol. Histopathol., 2001, 16, 309-317.
55. Lam, M.; Oleinick, N.L.; Nieminen, A.L. Photodynamic therapyinduced apoptosis in epidermoid carcinoma cells. Reactive oxygen species and mitochondrial inner membrane permeabilization. J. Biol. Chem., 2001, 276, 47379-47386.
56. Xue, L.Y.; Chiu, S.M.; Oleinick, N.L. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: A role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Exp. Cell Res., 2001, 263, 145-155.
57. Geze, M.; Morliere, P.; Maziere, J.C.; Smith, K.M.; Santus, R. Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications. J. Photochem. Photobiol. B, 1993, 20, 23-35.
58. Berg, K.; Moan, J. Lysosomes as photochemical targets. Int. J. Cancer, 1994, 59, 814-822.
59. MacDonald, I.J.; Morgan, J.; Bellnier, D.A.; Paszkiewicz, G.M.; Whitaker, J.E.; Litchfield, D.J.; Dougherty, T.J. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives. Photochem. Photobiol., 1999, 70, 789-797.
60. Kessel, D.; Luo, Y. Intracellular sites of photodamage as a factor in apoptotic cell death. JPP, 2001, 5, 181-184.
61. Reiners, J.J. Jr.; Caruso, J.A.; Mathieu, P.; Chelladurai, B.; Yin, X. M.; Kessel, D. Release of cytochrome c and activation of procaspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ., 2002, 9, 934-944.
62. Dummin, H.; Cernay, T.; Zimmermann, H.W. Selective photosensitization of mitochondria in HeLa cells by cationic Zn (II) phthalocyanines with lipophilic side-chains. J. Photochem. Photobiol. B, 1997, 37, 219-229.
63. Rashid, F.; Horobin, R.W. Interaction of molecular probes with living cells and tissues. Part 2. A structure-activity analysis of mitochondrial staining by cationic probes, and a discussion of the synergistic nature of image-based and biochemical approaches. Histochemistry, 1990, 94, 303-308.
64. Varnes, M.E.; Chiu, S.M.; Xue, L.Y.; Oleinick, N.L. Photodynamic Therapy- Induced Apoptosis in Lymphoma Cells: Translocation of cytochrome c causes inhibition of respiration as well caspase activation. Biochem. Biophys. Res. Commun., 1999, 6, 28-35.
65. An, Y.P.; Xiao, R.; Cui, H.; Cui, Z.J. Selective activation by photodynamic action of cholecystokinin receptor in the freshly isolated rat pancreatic acini. Br. J. Pharmacol., 2003, 139, 872-880.
66. Ruck, A.; Heckelsmiller, K.; Kaufmann, R.; Grossman, N.; Haseroth, E.; Akgun, N. Light-induced apoptosis involves a defined sequence of cytoplasmic and nuclear calcium release in AlPcS4-photosensitized rat bladder RR 1022 epithelial cells. Photochem. Photobiol., 2000, 72, 210-216.
67. Tsai, J.C.; Wu, C.L.; Chien, H.F.; Chen, C.T. Reorganization of cytoskeleton induced by5-Aminolevulinicacid-mediated photodynamic therapy and its correlation with mitochondrial dysfunction. Lasers Surg. Med., 2005, 36, 398-408.
68. Pluskalova, M.; Peslova, G.; Grebenova, D.; Halada, P.; Hrkal, Z. Photodynamic treatment (ALA-PDT) suppresses the expression of the oncogenic Bcr-Abl kinase and affects the cytoskeleton organization in K562 cells. J. Photochem. Photobiol. B. Biol., 2006, 83, 205-212.
69. Margaron, P.; Sorrenti, R.; Levy, J.G. Photodynamic therapy inhibits cell adhesion without altering integrin expression. Biochim. Biophys. Acta, 1997, 1359, 200-210.
70. Volden, G.; Christensen, T.; Moan, J. Photodynamic membrane damage of hematoporphyrin derivative-treated NHIK 3025 cells in vitro. Photobiochem. Photobioph., 1981, 3, 105-111.
71. Specht, K.G.; Rodgers, M.A. Depolarization of mouse myeloma cell membranes during photodynamic action. Photochem. Photobiol., 1990, 51, 319-324.
72. Thomas, J.P.; Girotti, A.W. Role of lipid peroxidation in hematoporphyrin derivative-sensitized photo killing of tumour cells: protective effects of glutathione peroxidase. Cancer Res., 1989, 49, 1682-1686.
73. Allison, R.R.; Mang, T.S.; Wilson, B.D. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin. Cutan. Med. Surg., 1998, 17, 153-163.
74. Taber, S.W.; Fingar, V.H.; Wieman, T.J. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J. Surg. Oncol., 1998, 68, 209-214.
75. Allison, R.; Mang, T.; Hewson, G. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer, 2001, 91, 1-8.
76. Cuenca, R.E.; Allison, R.R.; Sibata, C. Breast cancer with chest wall progression: Treatment with photodynamic therapy. Ann. Surg. Oncol., 2004, 11, 322-327.
77. Salonen, J.T.; Nyysonen, K.; Salonen, R. Antioxidant supplementations in atherosclerosis prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J. Intern. Med., 2000, 248, 377-386.
78. Friedman, M. Overview of antibacterial, antitoxin, antiviral and antifungal activities of tea flavonoids and teas. Mol. Nutr. Food Res., 2007, 51, 116-134.
79. Hemaiswarya, S.; Doble, M. Potential synergism of natural products in the treatment of cancer. Phytother. Res., 2006, 20, 239-249.
80. Hwang, J.W.; Oh, J.H.; Yoo, H.S.; Lee, Y.W.; Cho, C.K.; Kwon, K.R. Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-kappa B. Am. J. Chin. Med., 2012, 40, 187-202.
81. Yang, S.; Zhao, Q.; Xiang, H.; Liu, M.; Zhang, Q.; Xue, W. Antiproliferative activity and apoptosis-inducing mechanism of constituents from Toonasinensis on human cancer cells. Cancer Cell Int., 2013, 13, 12.
82. Davis, J.N.; Kucuk, O.; Sarkar, F.H. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr. Cancer, 1999, 35, 167-174.
83. Cragg, G.M.; Newman, D.J. Plants as a source of anticancer agents. J. Ethnopharmacol., 2005, 100, 72-79.
84. Russo, M.; Tedesco, I.; Iacomino, G.; Palumbo, R.; Galano, G.; Russo, G.L. Dietary phytochemical in chemoprevention of cancer. Curr. Med. Chem. Immun. Endoc. Meta. Agents, 2005, 5, 61-72.
85. Schwartz, G.K.; Shah, M.A. Targeting the cell cycle: A new approach to cancer therapy. J. Clin. Oncol., 2005, 23, 9408-9421.
86. Purohit, A.; Hejaz, H.A.; Walden, L.; MacCarthy-Morrogh, L.; Packam, G.; Potter, B.V. The effect of 2-methoxyoestrone-3-O- sulphamate on the growth of breast cancer cells and induced mammary tumours. Int. J. Cancer, 2000, 85, 584-589.
87. Harada, H.; Yamashita, U.; Kurihara, H.; Fukushi, E.; Kawabata, J.; Kamei, Y. Antitumour activity of palmitic acid found as a selective cytotoxic substance in a marine red alga. Anticancer Res., 2002, 22, 2587-2590.
88. Cheng, Y.L.; Chang, W.L.; Lee, S.C.; Liu, Y.G.; Chen, C.J.; Lin, S. Z. Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis. Life Sci., 2004, 75, 1579-1594.
89. Sun, J.; Liu, R.H. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett., 2006, 241, 124-134.
90. Hu, X.; Zhang, X.; Qiu, S.; Yu, D.; Lin, S. Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun., 2010, 398, 62-67.
91. Choi, Y.H.; Lee, W.H.; Park, K.Y.; Zhang, L. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. JPN. J. Cancer Res., 2000, 91, 164-173.
92. Lee, J.H.; Khor, T.O.; Shu, L.; Su, Z.Y.; Fuentes, F.; Kong, A.N.; Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacol. Ther., 2013, 137, 153-171.
93. Nobili, S.; Lippi, D.; Witort, E.; Donnini, M.; Bausi, L.; Mini, E. Natural compounds for cancer treatment and prevention. Pharmacol. Res., 2009, 59, 365-378.
94. Hu, W.; Tin, O.K.; Limin, S.; Zheng-Yuan, S.; Francisco, F.; Jong-Hun, L.; Ah-Ng, T.K. Plants vs. Cancer: A review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med. Chem., 2012, 12, 1281-1305.
95. Sherr, C.J. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res. 2000, 60, 3689-3695.
96. Sorensen, C.; Charpentier, R.; Benson, E. Cell cycle regulatory proteins and structural proteins as markers of apoptosis. Am. Biotechnol. Lab., 2000, 17, 20-22.
97. Harbour, J.W.; Dean, D.C. Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol., 2000, 2, 65-67.
98. Hussain, S.P.; Harris, C.C. Molecular epidemiology and carcinogenesis: Endogeneous and exogenous carcinogens. Mutation Res., 2002, 462, 311-322.
99. McKenzie, K.E.; Siva, A.; Maier, S.; Runnebaum, I.B.; Seshadri, R.; Sukumar, S. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations. Clin. Cancer Res., 1997, 3, 1669-1673.
100. Keshava, C.; Frye, B.L.; Wolff, M.S.; McCanlies, E.C.; Weston, A. Waf-1 (p21) and p53 polymorphisms in breast cancer. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 127-130.
101. Foster, J.S.; Wimalasena, J. Estrogen regulates activity of cyclin dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol., 1996, 10, 488-498.
102. Rafi, M.M.; Vastano, B.C.; Zhu, N.; Ho, C.T.; Ghai, G.; Rosen, R. T. Novel polyphenol molecule isolated from licorice root (Glycrrhizaglabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines. J. Agric. Food Chem., 2002, 50, 677-684.
103. Cai, X.Z.; Wang, J.; Li, X.D.; Wang, G.L.; Liu, F.N.; Cheng, M. S.; Li, F. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol. Ther., 2009, 8, 1360-1368.
104. Yu, C.; Minemoto, Y.; Zhang, J.; Liu, J.; Tang, F.; Bui, T.N.; Xiang, J.; Lin, A. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Molecular Cell, 2004, 13, 329-340.
105. Hirai, I.; Wang, H.G. Survival-factor-induced phosphorylation of Bad results in its dissociation from Bcl-xL but not Bcl-2. Biochem. J., 2001, 359, 345-352.
106. Huang, D.C.; Strasser, A. BH3-only proteins-essential initiators of apoptotic cell death. Cell, 2000, 103, 839-842.
107. Xiao, D.; Choi, S.; Johnson, D.E.; Vogel, V.G.; Johnson, C.S.; Trump, D.L. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N terminal kinase and extracellular- signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene, 2004, 23, 5594-5606.
108. Mehmet, H. Apoptosis: Caspase find a new place to hide. Nature 2002, 403, 29-30.
109. Hu, H.; Ahn, N.S.; Yang, X.; Lee, Y.S.; Kang, K.S. Ganoder malucidum extract induces cell cycle arrest and apoptosis inMCF-7 human breast cancer cell. Int. J. Cancer, 2002, 102, 250-253.
110. Nicholson, D.W. Caspase structure, proteolytic substrates, and functioning during apoptotic cell death. Cell Death Diff., 1999, 6, 1028-1042.
111. Yuan, J.Y.; Shaham, S.; Ledoux, S.; Ellis, H.M.; Horvitz, H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell, 1993, 75, 641-652.
112. Dixon, S.C.; Sorianon, B.J.; Lush, R.M.; Borner, M.M.; Figg, W. D. Apoptosis: Its role in the development of malignancies and its potential as a novel therapeutic target. Ann. Pharmacother., 1997, 31, 76-82.
113. Surh, Y.J. Molecular mechanism of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res., 1999, 428, 305-327.
114. Rodriguez-Rocha, H.; Garcia-Garcia, A.; Panayiotidis, M.I.; Franco, R. DNA damage and autophagy. Mutat. Res., 2011, 711, 158-166.
115. Abedin, M.J.; Wang, D.; McDonnell, M.A.; Lehmann, U.; Kelekar, A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Diff., 2007, 14, 500-510.
116. Cui, Q.; Tashiro, S.I.; Onodera, S.; Minami, M.; Ikejima, T. Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells. Biol. Pharm. Bull., 2007, 30, 859-864.
117. Liang, J.; Shao, S. H.; Xu, Z.X. The energy sensing LKB1- AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis. Nature Cell Biol., 2007, 9, 218-224.
118. Tasdemir, E.; Maiuri, M.C.; Galluzzi, L. Regulation of autophagy by cytoplasmic p53. Nature Cell Biol., 2008, 10, 676-687.
119. Prasanna, R.; Chandramoorthy, H.C.; Ramaiyapillai, P.; Sakthisekaran, V. In vitro evaluation of anticancer effect of Cassia auriculata leaf extract and curcumin through induction of apoptosis in human breast and larynx cancer cell lines. Biomed. Prev. Nutr., 2011, 1, 153-160.
120. Qin, J.J.; ZiJin, H.; Huang, Y.; Zhang, S.D.; Shan, L.; Voruganti, S.; Nag, S.; Wang, W.; Zhang, W.D.; Zhang, R. Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula linearii folia Turcz. Eur. J. Med. Chem., 2013, 68, 473-481.
121. Tan, M.L.; Sulaiman, S.F.; Najimuddin, N.; Samian, M.R.; Muhammad, T.S. Methanolic extract of Pereskia bleo (Kunth) DC. (Cactaceae) induces apoptosis in breast carcinoma, T47-D cell line. J. Ethnopharmacol., 2005, 96, 287-294.
122. Abhyankar, G.P.; Suprasanna, B.N.; Pandey, K.P.; Mishra, K.V.; Rao, V.D. Hairy root extract of Phyllanthus amarus induces apoptotic cell death in human breast cancer cells. Innov. Food Sci. Emerg. Technol., 2010, 11, 526-532.
123. Saleem, A.; Husheem, M.; Harkonen, P.; Pihlaja, K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. Fruit. J. Ethnopharmacol., 2002, 81, 327-336.
124. Tanih, N.F.; Ndip, R.N. The acetone extract of Sclerocarya birrea (Anacardiaceae) Possesses antiproliferative and apoptotic potential against human breast cancer cell lines (MCF-7). Scient. World J., 2013.
125. Chong, H.Z.; Yeap, S.K.; Rahmat, A.; Akim, A.M.; Alitheen, N. B.; Othman, F.; Gwendoline-Ee, C.L. In vitro evaluation of Pandanus amaryllifolius ethanol extract for induction of cell death on non-hormone dependent human breast adeno carcinoma MDA- MB-231 cell via apoptosis. BMC Complement. Altern. Med., 2012, 12, 134.
126. Bakar, M.F.A.; Mohamad, M.; Rahmat, A.; Steven, A.B.; Jeffrey Fry, R. Cytotoxicity, cell cycle arrest, and apoptosis in breast cancer cell lines exposed to an extract of the seed kernel of Mangifera pajang (bambangan). Food Chem. Toxicol., 2010, 48, 1688-1697.
127. Armania, N.; Yazan, L.S.; Ismail, S.I.; Foo, J.B.; Tor, Y.S.; Ismail, N.N.; Maznah Ismail, M. Dillenia suffruticosa extract inhibits Anti-Cancer Agents in Medicinal Chemistry, 2016, Vol. 16, No. 7 801 proliferation of human breast cancer cell lines (MCF-7 and MDA- MB-231) via induction of G2/M arrest and apoptosis. Molecules, 2013, 18, 13320-13339.
128. Plastina, P.; Bonofiglio, D.; Vizza, D.; Fazio, A.; Rovito, D.; Giordano, C.; Barone, I.; Catalano, S.; Gabriele, B. Identification of bioactive constituents of Ziziphus jujube fruit extracts exerting antiproliferative and apoptotic effects in human breast cancer cells. J. Ethnopharmacol., 2012, 140, 325-332.
129. Majid, M.Z.; Zaini, Z.M.; Razak, F.A. Apoptosis inducing effect of three medicinal plants on oral cancer cells KB and ORL-48. Scientific World J., 2014.
130. George, B.P.; Thangaraj, P.; Kumar, Y.T.; Thankarajan, S. Antitumour and wound healing properties of Rubus ellipticus Smith. J. Acupunct. Meridian Stud., 2015, 8, 134-141.
131. George, B.P.; Thangaraj, P.; Thankarajan, S.; Saravanan, S. Antitumour and wound healing properties of Rubus niveus Thunb. root. J. Environ. Pathol. Toxicol. Oncol., 2014, 33, 145-158.
132. George, B.P.; Tynga, I.M.; Abrahamse, H. In vitro antiproliferative effect of the acetone extract of Rubus fairholmianus Gard. root on human colorectal cancer (Caco-2) cells. Biomed Res. Int. 2015.
133. George, B.P.; Thangaraj, P.; Sulaiman, C.; Piramanayagam, S.; Ramaswamy, S.K. Bioassay directed isolation and biological evaluation of compounds isolated from Rubus fairholmianus Gard. Bio.Med.Res. Int., 2014.
134. Elumalai, P.; Gunadharini, D.N.; Senthilkumar, K.; Banudevi, S.; Arunkumar, R.; Benson, C.S.; Sharmila, G.; Arunakaran, J. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicol. Lett., 2012, 215, 131-142.
135. Arunasree, K.M. Antiproliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 23. Phytomedicine, 2010, 17, 581-588.
136. Deepa, M.; Sureshkumar, T.; Satheeshkumar, P.K.; Priya, S. Purified mulberry leaf lectin (MLL) induces apoptosis and cell cycle arrest in human breast cancer and colon cancer cells. Chem. Biol. Interact., 2012, 200, 38-44.
137. Liu, Z.; Liu, M.; Liu, M.; Jianchun, Li. Methylanthraquinone from Hedyotis diffusa WILLD induces Ca2+-mediated apoptosis in human breast cancer cells. Toxicol. In vitro, 2010, 24, 142-147.
138. Noble, R.L. The discovery of the vinca alkaloids chemotherapeutic agents against cancer. Biochem. Cell Biol., 1990, 68, 1344-1351.
139. Creemers, G.J.; Bolis, G.; Gore, M.; Scarfone, G.; Lacave, A.J.; Guastalla, J.P.; Despax, R.; Favalli, G.; Kreinberg, R.; Van Belle, S. Topotecan, anactive drug in the second-line treatment of epithelial ovarian cancer. J. Clin. Oncol., 1996, 14, 3056-3061.
140. Losiewicz, M.D.; Carlson, B.A.; Kaur, G.; Sausville, E.A. Worland PJ: Potent inhibition of cdc2 kinase activity by the flavonoid L86- 8275. Biochem. Biophys. Res. Commun., 1994, 201, 589-595.